Oxford Sciences Enterprises (OSE)

The University of Oxford produced more start-ups (worth >$1bn) than any other European university over the past decade, aiming to create 20 new companies per year going forward. OSE’s portfolio spans life sciences, deep tech, health tech and software and AI, tackling challenges like the diagnosis and treatment of devastating rare diseases, cancer, sustainability, nuclear fusion, quantum computing and cyber-security.

We have the privilege of supporting the growth of these companies at the cutting edge of science by building a strategic pipeline of real estate. Our role is to support in delivering a real estate strategy, acquire buildings, and fit out for laboratory, R&D, or technical use.

Beneath the H B Allen Centre, we delivered OSE’s award-winning ‘Grassroots’ incubator. We have also been identifying and converting commercial stock into laboratories, including the Schrodinger and Sherard Buildings, providing advice and services to 30+ OSE portfolio companies.